Novel siRNA reduces plasma lipoprotein(a) levels
- PMID: 35079155
- DOI: 10.1038/s41569-022-00673-1
Novel siRNA reduces plasma lipoprotein(a) levels
Comment on
-
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a).Nat Med. 2022 Jan;28(1):96-103. doi: 10.1038/s41591-021-01634-w. Epub 2022 Jan 13. Nat Med. 2022. PMID: 35027752 Clinical Trial.
References
Original article
-
- Koren, M. J. et al. Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a). Nat. Med. https://doi.org/10.1038/s41591-021-01634-w (2022) - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources